TABLE 1

Characteristics of patients (n = 89)

Data are expressed as number or mean ± S.D.


Variables

Whole (n = 89)

Treatment with PPIs
Omeprazole (n = 35)
Lansoprazole (n = 54)
Age, years 51.9 ± 10.3 52.4 ± 8.8 51.6 ± 11.2
Gender (male/female), n 46/43 19/16 27/27
Body weight, kg 60.0 ± 10.0 59.8 ± 10.2 60.1 ± 9.9
Graft-to-recipient weight ratio, % 1.14 ± 0.30 1.15 ± 0.29 1.13 ± 0.30
ABO blood group match (identical/compatible/incompatible), n 60/12/17 24/4/7 36/8/10
Primary disease, n
    Cirrhosis 70 30 40
    Primary biliary cirrhosis 7 2 5
    Fulminant hepatic failure 3 1 2
    Others 9a 2 7
Donor age, years 45.0 ± 13.2 46.0 ± 12.6 44.3 ± 13.6
Donor gender (male/female), n
50/39
18/17
32/22
  • a The primary disease was biliary atresia, Budd-Chiari syndrome, nonalcoholic steatohepatitis, and primary sclerosing cholangitis.